| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |